Download PDF

1. Company Snapshot

1.a. Company Description

Acadia Healthcare Company, Inc.provides behavioral healthcare services in the United States and Puerto Rico.The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics.


As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds.The company was founded in 2005 and is headquartered in Franklin, Tennessee.

Show Full description

1.b. Last Insights on ACHC

Breaking News: Acadia Healthcare Company Inc reported no recent earnings release. The company presented at the 47th Annual Raymond James Institutional Investor Conference. Short interest in the company rose 23.1% in February, with 32,453,225 shares shorted as of February 13th, representing 35.9% of its shares. No analyst recommendations were available. Some analysts previously recommended a buy or hold on the stock. The short interest growth may indicate a potential increase in volatility. The presentation at the conference may provide insights into the company's strategy. Short sellers currently bet against the company.

1.c. Company Highlights

2. Acadia Healthcare's Operational Excellence Drive Yields Mixed Results

Acadia Healthcare's fourth-quarter revenue reached $821.5 million, representing a 6.1% increase over the same period last year. Adjusted EBITDA for the quarter was $99.8 million. For the full year 2025, the company generated revenue of $3.31 billion, a 5% increase over the prior year, and adjusted EBITDA of $608.9 million. However, the actual EPS came out at -13.0196, significantly lower than estimates of 0.03. The company's guidance for 2026 expects revenue to be between $3.37 billion and $3.45 billion, with adjusted EBITDA ranging from $575 million to $610 million.

Publication Date: Feb -26

📋 Highlights
  • Revenue Growth:: FY2025 revenue reached $3.31B (+5% YoY), with 2026 guidance at $3.37B–$3.45B.
  • Adjusted EBITDA:: FY2025 adjusted EBITDA was $608.9M; 2026 guidance set at $575M–$610M.
  • Bed Expansion:: Added 2,500 beds in 3 years; plans to add 400–600 beds in 2026.
  • Operational Shift:: Transitioning from expansion to operational excellence, with same-facility volume growth of 0%–1% in 2026.
  • Quality Initiatives:: Expanding real-time quality dashboards (tracking 50+ metrics) and outcomes data in 2026.

Operational Challenges and Opportunities

The company's operational priorities are focused on execution and quality patient care. According to Debra Osteen, "We're expanding outcomes tracking across more programs in 2026, so we can be more transparent about patient progress over time." The company has added over 2,500 beds in the past three years and is on track to add another 400 to 600 beds in 2026. The ramping facilities opened between 2023 and 2025 are now at higher occupancy levels, driving greater leverage in EBITDA, as noted by Todd Young.

Valuation and Growth Prospects

Analysts estimate the company's revenue growth at 5.4% for the next year. The current valuation metrics show a P/E Ratio of -1.71, P/B Ratio of 0.97, and P/S Ratio of 0.57. The EV/EBITDA ratio is -5.96, indicating a potentially undervalued stock. However, the ROE is -39.42%, and the Net Debt / EBITDA is -3.4, suggesting some concerns regarding the company's financial health.

Key Drivers and Risks

The company's performance is expected to be influenced by factors such as managed Medicaid pressure on average length of stay, bed closures, and changes in California's staffing requirements. Todd Young mentioned that the company expects a $4 million EBITDA impact due to a higher nurse-to-patient ratio in California. The referral channel mix has remained relatively stable, with a focus on building relationships and connecting with referral sources.

3. NewsRoom

Card image cap

Acadia Healthcare Touts Faster Bed Ramp, Reaffirms 2026 Outlook, Eyes Positive Free Cash Flow

10:08

Source: defenseworld.net

Card image cap

Acadia Healthcare Stock Has Tanked This Past Year, and One Fund Just Called It Quits on a $13 Million Stake

Mar -03

Source: fool.com

Card image cap

Short Interest in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Rises By 23.1%

Mar -03

Source: defenseworld.net

Card image cap

Acadia Healthcare Company, Inc. (ACHC) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript

Mar -02

Source: seekingalpha.com

Card image cap

Acadia Healthcare: New Management Deserves A Shot At Turning Business Around

Feb -26

Source: seekingalpha.com

Card image cap

Acadia Healthcare Company, Inc. (ACHC) Q4 2025 Earnings Call Transcript

Feb -25

Source: seekingalpha.com

Card image cap

Acadia Healthcare Q4 Earnings Beat Estimates on Rising Admissions

Feb -25

Source: zacks.com

Card image cap

Acadia Healthcare (ACHC) Surpasses Q4 Earnings and Revenue Estimates

Feb -25

Source: zacks.com

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (9.46%)

6. Segments

Acute Inpatient Psychiatric Facilities

Expected Growth: 9%

Acadia Healthcare's Acute Inpatient Psychiatric Facilities segment growth is driven by increasing demand for mental health services, aging population, and shortage of psychiatric beds. Additionally, the company's strategic acquisitions, expanded payer contracts, and improved operational efficiencies contribute to the 9% growth rate.

Specialty Treatment Facilities

Expected Growth: 8%

Acadia Healthcare's Specialty Treatment Facilities segment growth is driven by increasing demand for behavioral health services, expansion of existing facilities, and strategic acquisitions. Additionally, the company's focus on providing high-quality, patient-centered care and its ability to navigate regulatory changes have contributed to its 8% growth rate.

Comprehensive Treatment Centers

Expected Growth: 11%

Acadia Healthcare's Comprehensive Treatment Centers segment growth is driven by increasing demand for opioid treatment services, expansion into new markets, and strategic acquisitions. Additionally, the company's focus on providing high-quality patient care, investing in technology, and building strong relationships with healthcare providers and payers contribute to its 11% growth rate.

Residential Treatment Centers

Expected Growth: 12%

Acadia Healthcare's Residential Treatment Centers segment growth is driven by increasing demand for behavioral health services, expansion of existing facilities, and strategic acquisitions. Additionally, the company's focus on quality care and patient outcomes, as well as its ability to navigate regulatory changes, contribute to its 12% growth rate.

7. Detailed Products

Behavioral Health Services

Acadia provides a range of behavioral health services, including inpatient and outpatient care, for individuals struggling with mental health and substance abuse issues.

Addiction Treatment Services

Acadia offers specialized addiction treatment services, including detoxification, rehabilitation, and aftercare programs, to help individuals overcome addiction.

Autism Services

Acadia provides autism services, including diagnostic assessments, therapy, and behavioral interventions, to support individuals with autism spectrum disorder (ASD).

Eating Disorders Treatment

Acadia offers specialized treatment programs for individuals struggling with eating disorders, including anorexia nervosa, bulimia nervosa, and binge eating disorder.

Medication-Assisted Treatment (MAT)

Acadia provides medication-assisted treatment (MAT) programs, which combine medication with counseling and behavioral therapies to treat opioid use disorder.

Outpatient Services

Acadia offers outpatient services, including counseling, therapy, and medication management, for individuals who require ongoing support and treatment.

8. Acadia Healthcare Company, Inc.'s Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for Acadia Healthcare Company, Inc. is medium due to the availability of alternative mental health services and treatment options.

Bargaining Power Of Customers

The bargaining power of customers for Acadia Healthcare Company, Inc. is low due to the lack of negotiating power of individual patients and the complexity of mental health services.

Bargaining Power Of Suppliers

The bargaining power of suppliers for Acadia Healthcare Company, Inc. is medium due to the presence of multiple suppliers of goods and services, but the company's dependence on a few key suppliers.

Threat Of New Entrants

The threat of new entrants for Acadia Healthcare Company, Inc. is low due to the high barriers to entry, including regulatory hurdles and the need for specialized expertise and facilities.

Intensity Of Rivalry

The intensity of rivalry for Acadia Healthcare Company, Inc. is high due to the presence of several established competitors in the mental health services industry, leading to a competitive market.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 33.46%
Debt Cost 8.80%
Equity Weight 66.54%
Equity Cost 10.53%
WACC 9.95%
Leverage 50.29%

11. Quality Control: Acadia Healthcare Company, Inc. passed 1 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Amedisys

A-Score: 5.6/10

Value: 4.4

Growth: 4.6

Quality: 6.9

Yield: 0.0

Momentum: 8.0

Volatility: 10.0

1-Year Total Return ->

View Full Report
Stock-Card
Ensign Group

A-Score: 5.5/10

Value: 2.6

Growth: 7.4

Quality: 4.7

Yield: 0.0

Momentum: 9.0

Volatility: 9.0

1-Year Total Return ->

View Full Report
Stock-Card
Option Care Health

A-Score: 5.4/10

Value: 4.0

Growth: 7.2

Quality: 6.8

Yield: 0.0

Momentum: 8.0

Volatility: 6.7

1-Year Total Return ->

View Full Report
Stock-Card
Chemed

A-Score: 4.5/10

Value: 3.5

Growth: 6.0

Quality: 7.3

Yield: 0.0

Momentum: 2.0

Volatility: 8.3

1-Year Total Return ->

View Full Report
Stock-Card
Select Medical

A-Score: 4.4/10

Value: 7.7

Growth: 4.3

Quality: 4.0

Yield: 4.0

Momentum: 1.0

Volatility: 5.3

1-Year Total Return ->

View Full Report
Stock-Card
Acadia Healthcare

A-Score: 3.3/10

Value: 7.3

Growth: 4.1

Quality: 4.8

Yield: 0.0

Momentum: 0.0

Volatility: 3.3

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

23.01$

Current Price

23.01$

Potential

-0.00%

Expected Cash-Flows